Previous studies have confirmed BDNF-TrkB and related pathways downstream of its biological function, most of which adopt methods such as inducing excitatory neurotoxicity by glutamate, creating epileptic convulsions or depression models, or increasing exogenous BDNF. The gene discussed is NTRK2; the disease is depressive disorder.